What You Should Know:
– Accenture has made a strategic investment, through Accenture Ventures, in 1910 Genetics, a biotechnology company revolutionizing drug discovery with its AI-powered platform. Terms of the investment were not disclosed.
– The…
Continue Reading
What You Should Know:
– Quris-AI, a leading Bio-AI company revolutionizing drug development, has acquired Nortis, a pioneer in microphysiology systems (MPS) technology, formerly known as Numa Biosciences.
– The strategic acquisition will integrate Nortis’s advanced…
Continue Reading
What You Should Know:
– Frontier Bio Corporation has successfully created complex microscale lung tissue by combining 3D bioprinting with the self-assembling capabilities of stem cells, mirroring the natural organ development process.
– Frontier Bio’s breakthrough…
Continue Reading
What You Should Know:
– Gilead Sciences, a global biopharmaceutical company, and Genesis Therapeutics, an AI-focused biotechnology firm, have announced a strategic collaboration to discover and develop innovative small molecule therapies.
– The startegic partnership leverages…
Continue Reading
What You Should Know:
– Kahun, a pioneer in medical knowledge structuring, has introduced a new AI Agent specifically designed for the pharmaceutical industry.
– The AI Agent aims to bridge the gap between medical knowledge…
Continue Reading
Healthcare executives, investors and entrepreneurs have been confirmed to speak at the MedCity INVEST Digital Health conference scheduled for September 18 at Pegasus Park in Dallas. The conference will spotlight critical issues in healthcare such as…
Continue Reading
MedCity’s INVEST and INVEST Digital Health events offer compelling forums for discussion around the healthcare innovation ecosystem and its components, from startups in health tech and life sciences, venture capital and strategic investors, healthcare…
Continue Reading
What You Should Know: –Genomics plc (Genomics), a healthcare company transforming health through the power of genomics today announced a three-year extension of the company’s collaboration with Vertex Pharmaceuticals Incorporated (Vertex) (Nasdaq: VRTX) to…
Continue Reading
Virtual patients and digital patients/twins are two similar concepts gaining increasing attention in health care with goals to accelerate drug development and improve patients’ survival, but with their own limitations. Although methods have been…
Continue Reading
Several health system executives and healthcare entrepreneurs have been confirmed to speak at the MedCity INVEST Digital Health conference scheduled for September 18 at Pegasus Park in Dallas. The conference will spotlight critical issues…
Continue Reading
